Keeler Thomas Management LLC Cuts Stake in HCA Healthcare, Inc. (NYSE:HCA)

Key Points

• Keeler Thomas Management LLC sold 2,031 shares of HCA Healthcare in Q1, reducing their stake by 76.6%, leaving them with 621 shares worth approximately $215,000.
• HCA Healthcare reported earnings per share (EPS) of $6.84 for the recent quarter, outperforming analysts' estimate of $6.20 with revenues of $18.61 billion.
• The company will pay a quarterly dividend of $0.72 on September 30th, with a current annualized yield of 0.8%.

Keeler Thomas Management LLC lessened its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 76.6% in the first quarter, according to its most recent filing with the SEC. The institutional investor owned 621 shares of the company's stock after selling 2,031 shares during the period. Keeler Thomas Management LLC's holdings in HCA Healthcare were worth $215,000 as of its most recent SEC filing.

A number of other institutional investors have also bought and sold shares of HCA. Cheviot Value Management LLC purchased a new position in shares of HCA Healthcare during the first quarter valued at about $26,000. Atwood & Palmer Inc. bought a new position in shares of HCA Healthcare in the 1st quarter valued at about $28,000. Bartlett & CO. Wealth Management LLC lifted its holdings in shares of HCA Healthcare by 888.9% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock valued at $31,000 after acquiring an additional 80 shares during the last quarter. ORG Partners LLC lifted its holdings in shares of HCA Healthcare by 344.0% in the 1st quarter. ORG Partners LLC now owns 111 shares of the company's stock valued at $38,000 after acquiring an additional 86 shares during the last quarter. Finally, Migdal Insurance & Financial Holdings Ltd. lifted its holdings in shares of HCA Healthcare by 75.8% in the 1st quarter. Migdal Insurance & Financial Holdings Ltd. now owns 116 shares of the company's stock valued at $40,000 after acquiring an additional 50 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company's stock.

Wall Street Analyst Weigh In

Several analysts have issued reports on HCA shares. Baird R W downgraded shares of HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 15th. Bank of America downgraded shares of HCA Healthcare from a "buy" rating to a "neutral" rating and set a $394.00 price objective for the company. in a research note on Wednesday, July 16th. Barclays decreased their price objective on shares of HCA Healthcare from $416.00 to $390.00 and set an "overweight" rating for the company in a research note on Monday, July 28th. Wall Street Zen raised shares of HCA Healthcare from a "hold" rating to a "buy" rating in a research note on Saturday, July 5th. Finally, Royal Bank Of Canada decreased their price target on shares of HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating for the company in a research note on Monday, July 28th. Nine investment analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, HCA Healthcare currently has a consensus rating of "Moderate Buy" and an average target price of $395.69.

HCA Healthcare Stock Performance

Shares of HCA traded up $8.51 during trading hours on Friday, reaching $381.84. 1,015,992 shares of the company traded hands, compared to its average volume of 1,587,259. The stock has a market capitalization of $89.35 billion, a P/E ratio of 16.05, a P/E/G ratio of 1.20 and a beta of 1.39. The company has a quick ratio of 0.86, a current ratio of 0.98 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14. The business has a fifty day moving average price of $369.74 and a 200-day moving average price of $349.36.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, beating the consensus estimate of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The company had revenue of $18.61 billion for the quarter, compared to analyst estimates of $18.49 billion. During the same period in the prior year, the company earned $5.50 earnings per share. The firm's revenue was up 6.4% on a year-over-year basis. Equities analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th will be given a $0.72 dividend. The ex-dividend date is Tuesday, September 16th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.8%. HCA Healthcare's dividend payout ratio is 12.11%.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of the company's stock in a transaction dated Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total value of $5,797,585.36. Following the completion of the transaction, the chief operating officer owned 12,646 shares in the company, valued at approximately $4,670,420.72. This represents a 55.38% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 1.30% of the company's stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.